News Center

Discover all of the trending news of the Ipsen Group


124 results

Financial information

Ipsen reiterated its commitment to the Innobio-2 fund

On February 4, 2019, Ipsen was delighted to attend the presentation of the new CSF…

Group

Ipsen commits to making all its published scientific researc...

We aim to publish the results of our clinical studies in peer-reviewed medical and scientific…

Event

Ipsen announces 50 posters to be presented at the 2019 TOXIN...

TOXINS is a key conference for thought leaders – clinicians and researchers from academia and…

Group

Ipsen: a story of transformation and growth

On December 12th, at the closing ceremony of the prestigious French Finance congress, Financium, Aymeric Le Chatelier,…

Group

Ipsen Seasons greetings

​A New Year has come​ and it's a wonderful time to reflect on what matters…

People

Ipsen France signs milestone Cancer and Employment Charter a...

On Friday, 23rd November, Ipsen France celebrated a significant milestone by signing the Cancer & Employment Charter…

Group

Ipsen Group inaugurates new office in Singapore

Ipsen, a leading  biopharmaceutical group  dedicated to improving lives through innovative medicines in specialty care (oncology , neuroscience and rare diseases) and…

Group

“How France can leverage its attributes and deliver on its f...

Prior to joining Ipsen in 2016 as Chief Executive Officer, I lived in a number…

Oncology

How Ipsen is waging war on cancer by Bartek BEDNARZ

10/18/2018 By Bartek BEDNARZ, Senior Vice-President, Oncology Franchise In the past 12 months we are…

Oncology

Spread the word: it is Liver Cancer Awareness Month

October is Liver Cancer Awareness Month, a global initiative that aims to raise understanding of…

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2021